Dexcom Inc. Stock
€53.40
Your prediction
Dexcom Inc. Stock
Pros and Cons of Dexcom Inc. in the next few years
Pros
Cons
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | -0.740% | -0.260% | -4.305% | -7.750% | -6.141% | -48.898% | -33.703% |
| Baxter International | 0.800% | 1.051% | -6.677% | -40.412% | -10.263% | -62.368% | -79.403% |
| Teleflex Inc. | -0.290% | -1.961% | 6.952% | -11.504% | -1.961% | -57.265% | -71.910% |
| Dentsply Sirona Inc. | -1.030% | 1.189% | 0.989% | -9.083% | 6.465% | -72.316% | -80.880% |
Comments
News
2 Growth Stocks to Hold for the Next Decade
Over the past year, Intuitive Surgical (NASDAQ: ISRG) and DexCom (NASDAQ: DXCM) have faced headwinds, and have lagged the stock market as a result. Shares of the former are down 13% over the
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
Many pharmaceutical companies are looking to develop and market the now highly popular GLP-1 drugs, which help treat diabetes, help patients lose weight, and reduce their risk of a range of
DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?
It's been a tough year for DexCom (NASDAQ: DXCM), whose stock price is down 25% since the start of 2025. It's a surprising performance, given that the overall stock market has been doing well; you


